東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁 到查詢結果 [ subject:"Cyclin-dependent kinases- Therapeutic use." ]

切換: 標籤 | MARC模式 | ISBD

Therapeutic potential of cell cycle ...

Mir, Manzoor Ahmad.

FindBook

Google Book

Amazon

博客來

Therapeutic potential of cell cycle kinases in breast cancer

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Therapeutic potential of cell cycle kinases in breast cancer/ edited by Manzoor Mir.
其他作者:	Mir, Manzoor Ahmad.
出版者:	Singapore :Springer Nature Singapore : : 2023.,
面頁冊數:	xvii, 373 p. :ill., digital ;24 cm.
內容註:	Chapter 1 An introduction to breast cancer -- Chapter 2 Current treatment approaches to breast cancer. Chapter 3 Introduction to cell cycle and its regulators -- Chapter 4 Cell cycle and cancer -- Chapter 5 cell cycle dysregulation in breast cancer -- Chapter 6 Molecular Subtypes of breast cancer and CDK dysregulation -- Chapter 7 Breast tumor micro environment and CDks -- Chapter 8 CDK Dysregulation in Breast Cancer: A Bioinformatics Analysis -- Chapter 9 CDK1 Dysregulation in Breast Cancer -- Chapter 10 CDK4/CDK6 dysregulation in estrogen positive receptor breast cancers -- Chapter 11 Therapeutic implications of CDKs in Breast Cancer -- Chapter 12 Novel CDK Inhibitors in Breast Cancer -- Chapter 13 Targeting CDKs with other chemotherapeutic drugs- A combinatorial approach -- Chapter 14 CDKs in cell-cycle progression and therapeutic strategies in Human breast cancer -- Chapter 15 CDk inhibitor for treatment of breast cancer -- Chapter 16 Response of therapy in cell cycle regulatory genes in breast cancer -- Chapter 17 Different cyclins and their significance in Breast cancer.
Contained By:	Springer Nature eBook
標題:	Breast - Cancer -
電子資源:	https://doi.org/10.1007/978-981-19-8911-7
ISBN:	9789811989117

Therapeutic potential of cell cycle kinases in breast cancer
Therapeutic potential of cell cycle kinases in breast cancer[electronic resource] /edited by Manzoor Mir. - Singapore :Springer Nature Singapore :2023. - xvii, 373 p. :ill., digital ;24 cm.

Chapter 1 An introduction to breast cancer -- Chapter 2 Current treatment approaches to breast cancer. Chapter 3 Introduction to cell cycle and its regulators -- Chapter 4 Cell cycle and cancer -- Chapter 5 cell cycle dysregulation in breast cancer -- Chapter 6 Molecular Subtypes of breast cancer and CDK dysregulation -- Chapter 7 Breast tumor micro environment and CDks -- Chapter 8 CDK Dysregulation in Breast Cancer: A Bioinformatics Analysis -- Chapter 9 CDK1 Dysregulation in Breast Cancer -- Chapter 10 CDK4/CDK6 dysregulation in estrogen positive receptor breast cancers -- Chapter 11 Therapeutic implications of CDKs in Breast Cancer -- Chapter 12 Novel CDK Inhibitors in Breast Cancer -- Chapter 13 Targeting CDKs with other chemotherapeutic drugs- A combinatorial approach -- Chapter 14 CDKs in cell-cycle progression and therapeutic strategies in Human breast cancer -- Chapter 15 CDk inhibitor for treatment of breast cancer -- Chapter 16 Response of therapy in cell cycle regulatory genes in breast cancer -- Chapter 17 Different cyclins and their significance in Breast cancer.

This book highlights the interrelation between cell cycle regulators and breast cancer phenotypes. It reviews the roles of Cyclin-Dependent Kinases (CDK) in driving cell cycle progression, cell cycle checkpoints and dysregulation in breast cancer. It also examines the prognostic significance of CDKs in breast cancer. and CDK inhibitors for the treatment of metastatic breast cancer. Further, the book discusses the role of different G1 cyclins in differentiation, chromosome stability, and transcriptional regulation in breast cancer. Additionally, it examines the role of immunogenic effects of CDK inhibitors, the mechanism of resistance and the current clinical trials in breast cancer treatment. Towards the end, the book explores cell cycle regulation as an attractive target for targeted drug therapy in breast cancer. This book is a comprehensive yet concise resource for oncologists and researchers interested in exploring the therapeutic potential of Cyclin-Dependent Kinases in breast cancer.

ISBN: 9789811989117

Standard No.: 10.1007/978-981-19-8911-7doiSubjects--Topical Terms:

792963
Breast
--Cancer

LC Class. No.: RC280.B8

Dewey Class. No.: 616.99449

Therapeutic potential of cell cycle kinases in breast cancer
LDR:03093nmm a2200325 a 4500 001 2315432
003 DE-He213
005 20230303141245.0
006 m d
007 cr nn 008maaau
008 230902s2023 si s 0 eng d
020 $a 9789811989117 $q (electronic bk.)
020 $a 9789811989100 $q (paper)
024 7 $a 10.1007/978-981-19-8911-7 $2 doi
035 $a 978-981-19-8911-7
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.B8
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.99449 $2 23
090 $a RC280.B8 $b T398 2023
245 0 0 $a Therapeutic potential of cell cycle kinases in breast cancer $h [electronic resource] / $c edited by Manzoor Mir.
260 $a Singapore : $b Springer Nature Singapore : $b Imprint: Springer, $c 2023.
300 $a xvii, 373 p. : $b ill., digital ; $c 24 cm.
505 0 $a Chapter 1 An introduction to breast cancer -- Chapter 2 Current treatment approaches to breast cancer. Chapter 3 Introduction to cell cycle and its regulators -- Chapter 4 Cell cycle and cancer -- Chapter 5 cell cycle dysregulation in breast cancer -- Chapter 6 Molecular Subtypes of breast cancer and CDK dysregulation -- Chapter 7 Breast tumor micro environment and CDks -- Chapter 8 CDK Dysregulation in Breast Cancer: A Bioinformatics Analysis -- Chapter 9 CDK1 Dysregulation in Breast Cancer -- Chapter 10 CDK4/CDK6 dysregulation in estrogen positive receptor breast cancers -- Chapter 11 Therapeutic implications of CDKs in Breast Cancer -- Chapter 12 Novel CDK Inhibitors in Breast Cancer -- Chapter 13 Targeting CDKs with other chemotherapeutic drugs- A combinatorial approach -- Chapter 14 CDKs in cell-cycle progression and therapeutic strategies in Human breast cancer -- Chapter 15 CDk inhibitor for treatment of breast cancer -- Chapter 16 Response of therapy in cell cycle regulatory genes in breast cancer -- Chapter 17 Different cyclins and their significance in Breast cancer.
520 $a This book highlights the interrelation between cell cycle regulators and breast cancer phenotypes. It reviews the roles of Cyclin-Dependent Kinases (CDK) in driving cell cycle progression, cell cycle checkpoints and dysregulation in breast cancer. It also examines the prognostic significance of CDKs in breast cancer. and CDK inhibitors for the treatment of metastatic breast cancer. Further, the book discusses the role of different G1 cyclins in differentiation, chromosome stability, and transcriptional regulation in breast cancer. Additionally, it examines the role of immunogenic effects of CDK inhibitors, the mechanism of resistance and the current clinical trials in breast cancer treatment. Towards the end, the book explores cell cycle regulation as an attractive target for targeted drug therapy in breast cancer. This book is a comprehensive yet concise resource for oncologists and researchers interested in exploring the therapeutic potential of Cyclin-Dependent Kinases in breast cancer.
650 0 $a Breast $x Cancer $x Treatment. $3 792963
650 0 $a Cyclin-dependent kinases $x Therapeutic use. $3 3627812
650 0 $a Cell cycle. $3 766119
650 1 4 $a Cancers. $3 3596461
650 2 4 $a Cancer Therapy. $3 3594090
650 2 4 $a Cancer Genetics and Genomics. $3 3591654
700 1 $a Mir, Manzoor Ahmad. $3 3627811
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-19-8911-7
950 $a Biomedical and Life Sciences (SpringerNature-11642)